Page last updated: 2024-09-04

febuxostat and Stroke

febuxostat has been researched along with Stroke in 4 studies

Research

Studies (4)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	4 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Britnell, SR; Brown, JN; Chillari, KA	1
Ferdaus, MZ; Fujikawa, K; Nabika, T; Ngarashi, D; Ohara, H; Zahid, HM	1
Choi, HK; Kang, EH; Kim, SC; Lee, EB; Lee, YJ; Shin, A; Song, YW	1
Kang, EH; Kim, SC	1

Reviews

2 review(s) available for febuxostat and Stroke

Article	Year
The Role of Xanthine Oxidase Inhibitors in Patients with History of Stroke: A Systematic Review. Current vascular pharmacology, 2018, Volume: 16, Issue:6 Topics: Allopurinol; Disability Evaluation; Endothelium, Vascular; Enzyme Inhibitors; Febuxostat; Humans; Recovery of Function; Stroke; Treatment Outcome; Xanthine Oxidase	2018
Cardiovascular Safety of Urate Lowering Therapies. Current rheumatology reports, 2019, 07-24, Volume: 21, Issue:9 Topics: Allopurinol; Cardiovascular Diseases; Endothelium; Febuxostat; Gout; Gout Suppressants; Heart Failure; Humans; Hypertension; Hyperuricemia; Myocardial Infarction; Probenecid; Risk; Stroke; Uricosuric Agents; Xanthine Oxidase	2019

Other Studies

2 other study(ies) available for febuxostat and Stroke

Article	Year
Dual inhibition of NADPH oxidases and xanthine oxidase potently prevents salt-induced stroke in stroke-prone spontaneously hypertensive rats. Hypertension research : official journal of the Japanese Society of Hypertension, 2019, Volume: 42, Issue:7 Topics: Animals; Antioxidants; Blood Pressure; Cyclic N-Oxides; Enzyme Inhibitors; Febuxostat; Male; NADPH Oxidases; Oxidative Stress; Rats; Rats, Inbred SHR; Rats, Transgenic; Reactive Oxygen Species; Sodium Chloride; Spin Labels; Stroke; Ubiquinone; Xanthine Oxidase	2019
Comparative cardiovascular risk of allopurinol versus febuxostat in patients with gout: a nation-wide cohort study. Rheumatology (Oxford, England), 2019, 12-01, Volume: 58, Issue:12 Topics: Aged; Allopurinol; Cardiovascular Diseases; Cohort Studies; Febuxostat; Female; Gout; Gout Suppressants; Humans; Ischemic Attack, Transient; Male; Middle Aged; Mortality; Myocardial Infarction; Myocardial Revascularization; Proportional Hazards Models; Republic of Korea; Stroke	2019

Article

Year

Dual inhibition of NADPH oxidases and xanthine oxidase potently prevents salt-induced stroke in stroke-prone spontaneously hypertensive rats.

Hypertension research : official journal of the Japanese Society of Hypertension, 2019, Volume: 42, Issue:7

Topics: Animals; Antioxidants; Blood Pressure; Cyclic N-Oxides; Enzyme Inhibitors; Febuxostat; Male; NADPH Oxidases; Oxidative Stress; Rats; Rats, Inbred SHR; Rats, Transgenic; Reactive Oxygen Species; Sodium Chloride; Spin Labels; Stroke; Ubiquinone; Xanthine Oxidase

2019

Comparative cardiovascular risk of allopurinol versus febuxostat in patients with gout: a nation-wide cohort study.

Rheumatology (Oxford, England), 2019, 12-01, Volume: 58, Issue:12

Topics: Aged; Allopurinol; Cardiovascular Diseases; Cohort Studies; Febuxostat; Female; Gout; Gout Suppressants; Humans; Ischemic Attack, Transient; Male; Middle Aged; Mortality; Myocardial Infarction; Myocardial Revascularization; Proportional Hazards Models; Republic of Korea; Stroke

2019